StockNews.com Begins Coverage on CASI Pharmaceuticals (NASDAQ:CASI) : vimarsana.com

StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report released on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. CASI Pharmaceuticals Stock Performance NASDAQ CASI opened at $3.61 on Thursday. CASI Pharmaceuticals has a fifty-two week low of $1.85 and a fifty-two week […]

Related Keywords

United States , , Renaissance Technologies , Susquehanna International Group , Pharmaceuticals Daily , Citigroup Inc , Pharmaceuticals Stock Performance , Pharmaceuticals Inc , Virtu Financial , Free Report , Get Free Report , International Group , Casi Pharmaceuticals , Nasdaq Casi , Casi , Medical , Initiated Coverage , Stocknews Com ,